Beta-carotene, vitamin C, and vitamin e and cardiovascular diseases

被引:39
作者
Dagenais G.R. [1 ]
Marchioli R. [2 ]
Tognoni G. [3 ]
Yusuf S. [4 ]
机构
[1] Institut de Cardiologie de Québec, Hôpital Laval, Ste-Foy, Québec, G1V 4G5
[2] Consorzio Mario Negri Sud, Santa-Maria Imbaro
[3] Mario Negri Institute, Milano
[4] Hamilton General Hospital, McMaster University, Hamilton, ON
关键词
Ischemic Heart Disease; Carotene; Peripheral Artery Disease; Intermittent Claudication; Male Smoker;
D O I
10.1007/s11886-000-0084-4
中图分类号
学科分类号
摘要
Observational studies have shown an inverse relationship between consumption of fruits and vegetables high in beta-carotene, vitamins C and E, and ischemic heart disease (IHD) and stroke. In large observational studies, betacarotene reduced the risk of IHD events in men, particularly in smokers. In contrast, four large randomized trials did not reveal a reduction in cardiovascular events with beta-carotene use, and may, in fact, increase IHD and total mortality in male smokers. There have been only a few large observational studies and one randomized trial with vitamin C, which have shown no beneficial or deleterious impact of this vitamin on cardiovascular events. Most large observational studies have shown an inverse relationship between vitamin E and IHD. However, a meta-analysis of the four randomized trials done in Europe and America involving a total of 51,000 participants allocated to vitamin E or placebo for 1.4 to 6 years, did not demonstrate a reduction in cardiovascular and IHD mortality and nonfatal myocardial infarction. Currently, there are no data to support the use of these vitamins to reduce the risk of cardiovascular events. Trials are in progress to determine whether a longer duration of administration of vitamin E or the association of vitamin E with cofactors may reduce cardiovascular events. Copyright © 2000 by Current Science Inc.
引用
收藏
页码:293 / 299
页数:6
相关论文
共 44 条
[41]  
Stephens N.G., Parsons A., Schofield P.M., Et al., Randomized controlled trial of vitamin e in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS), Lancet, 347, pp. 781-786, (1996)
[42]  
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin e after myocardial infarction: Results of the GISSI-Prevenzione trial, Lancet, 354, (1999)
[43]  
Vitamin e supplementation and cardiovascular events in high-risk patients, N Engl J Med, 342, pp. 154-160, (2000)
[44]  
Steinberg D., Clinical trials of antioxidants in atherosclerosis: Are we doing the right things?, Lancet, 346, pp. 36-38, (1995)